New York Life Investment Management LLC Nuvation Bio Inc. Transaction History

New York Life Investment Management LLC

  • $9.34 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 05, 2024
SELL
$0.96 - $1.53 $4,638 - $7,392
-4,832 Reduced 2.25%
209,652 $316,000
Q3 2023

Nov 07, 2023
SELL
$1.26 - $2.1 $42,575 - $70,959
-33,790 Reduced 13.61%
214,484 $287,000
Q2 2023

Aug 04, 2023
SELL
$1.56 - $1.84 $56,649 - $66,817
-36,314 Reduced 12.76%
248,274 $446,000
Q1 2023

May 08, 2023
BUY
$1.6 - $2.48 $455,340 - $705,778
284,588 New
284,588 $472,000

Others Institutions Holding NUVB

# of Institutions
152
Shares Held
123M
Call Options Held
9.7K
Put Options Held
6.5K
View Full List

About Nuvation Bio Inc.

NUVB Quotes by TradingView
  • Ticker NUVB
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 217,244,000
  • Market Cap $480M
  • Description
  • Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting cyclin-dependent kinase (CDK)2, CDK4, and CDK6. It is also developing NUV-868, a selective oral small molecule BET inhibitor that e...
More about NUVB
Track This Portfolio

Track New York Life Investment Management LLC Portfolio

Follow New York Life Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York Life Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on New York Life Investment Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email